Ultime notizie per Ampio Pharmaceuticals (OTC:AMPE) Azioni

Ampio Pharmaceuticals

Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development of a potential treatment for osteoarthritis of the knee ("OAK") as part of its OA-201 development program ("OA-201 program" or "OA-201").

AMPIO PHARMS INC by Ampio Pharmaceuticals, Inc.

Ampio Pharmaceuticals Inc

Amper SA

Ampio Pharmaceuticals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AMPE#AMEX">AMPE</a>) reported quarterly losses of $(2.48) per share. This is a 31.11 percent increase over losses of $(3.60) per share from the same period last year.

Earnings

News

AMPE

Ampio Pharmaceuticals Q4 EPS $(2.48) Up From $(3.60) YoY

The Company today notified the NYSE American of its intention to voluntarily delist its shares of common stock from the NYSE American.&nbsp;

Ampio Reports Voluntary Delisting And SEC Deregistration

<h3>Gainers</h3>
<ul>
<li>Societal CDMO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCTL#NASDAQ">SCTL</a>) stock rose 132.6% to $1.07 during Thursday's regular session. The company's market cap stands at $112.1 million. </li>
<li>Enveric Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVB#NASDAQ">ENVB</a>) shares increased by 132.25% to $1.93. The market value of their outstanding shares is at $5.2 million. </li>
<li>Envoy Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCH#NASDAQ">COCH</a>) stock rose 47.29% to $5.17. The market value of their outstanding shares is at $101.0 million. </li>
<li>Tivic Health Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) shares moved upwards by 30.39% to $1.63. The market value of their outstanding shares is at $2.3 million. </li>
<li>Revance Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVNC#NASDAQ">RVNC</a>) stock moved upwards by 29.68% to $7.34. The company's market cap stands at $644.5 million. The company's, Q4 earnings came out yesterday. </li>
<li>Renalytix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNLX#NASDAQ">RNLX</a>) shares increased by 28.91% to $1.07. The company's market cap stands at $53.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Kineta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KA#NASDAQ">KA</a>) shares fell 42.5% to $1.3 during Thursday's regular session. The market value of their outstanding shares is at $13.5 million. </li>
<li>Ironwood Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRWD#NASDAQ">IRWD</a>) stock fell 39.89% to $9.09. The market value of their outstanding shares is at $1.4 billion. </li>
<li>Grifols (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRFS#NASDAQ">GRFS</a>) shares declined by 27.63% to $6.76. The company's market cap stands at $4.5 billion. </li>
<li>Ampio Pharmaceuticals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AMPE#AMEX">AMPE</a>) shares fell 24.35% to $1.74. The market value of their outstanding shares is at $1.9 million. </li>
<li>Gyre Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GYRE#NASDAQ">GYRE</a>) shares fell 22.37% to $19.25. The company's market cap stands at $1.6 billion. </li>
<li>Castle Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSTL#NASDAQ">CSTL</a>) stock fell 20.85% to $19.3. The market value of their outstanding shares is at $519.5 million. As per the press release, Q4 earnings came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

Envoy Medical, Inc. - Class A Common Stock

COCH

CSTL

ENVB

GRFS

GYRE

IRWD

RNLX

RVNC

SCTL

TIVC

12 Health Care Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Enveric Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVB#NASDAQ">ENVB</a>) stock rose 162.3% to $2.18 during Thursday's pre-market session. The company's market cap stands at $5.9 million. </li>
<li>Societal CDMO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCTL#NASDAQ">SCTL</a>) shares moved upwards by 134.78% to $1.08. The company's market cap stands at $113.1 million. </li>
<li>NeuroBo Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRBO#NASDAQ">NRBO</a>) shares increased by 45.11% to $7.43. The company's market cap stands at $36.4 million. </li>
<li>OneMedNet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONMD#NASDAQ">ONMD</a>) stock moved upwards by 28.97% to $0.89. The market value of their outstanding shares is at $28.7 million. </li>
<li>Establishment Labs Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESTA#NASDAQ">ESTA</a>) stock increased by 21.91% to $46.89. The market value of their outstanding shares is at $1.2 billion. As per the press release, Q4 earnings came out yesterday. </li>
<li>Avidity Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNA#NASDAQ">RNA</a>) shares moved upwards by 20.64% to $18.41. The market value of their outstanding shares is at $1.4 billion. As per the press release, Q4 earnings came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Ironwood Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRWD#NASDAQ">IRWD</a>) shares decreased by 27.7% to $10.94 during Thursday's pre-market session. The company's market cap stands at $1.7 billion. </li>
<li>Milestone Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIST#NASDAQ">MIST</a>) stock fell 20.19% to $1.7. The market value of their outstanding shares is at $56.9 million. </li>
<li>Butterfly Network (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFLY#NYSE">BFLY</a>) stock fell 14.19% to $1.27. The company's market cap stands at $263.0 million. The company's, Q4 earnings came out yesterday. </li>
<li>Schrodinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDGR#NASDAQ">SDGR</a>) stock fell 13.3% to $27.2. The market value of their outstanding shares is at $1.9 billion. The company's, Q4 earnings came out yesterday. </li>
<li>ClearPoint Neuro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPT#NASDAQ">CLPT</a>) shares declined by 13.22% to $6.7. The company's market cap stands at $164.9 million. </li>
<li>Ampio Pharmaceuticals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AMPE#AMEX">AMPE</a>) stock fell 13.05% to $2.0. The market value of their outstanding shares is at $2.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BFLY

CLPT

ESTA

MIST

NRBO

ONMD

SDGR

12 Health Care Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>IGC Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IGC#AMEX">IGC</a>) shares moved upwards by 14.6% to $0.4 during Wednesday's after-market session. The market value of their outstanding shares is at $25.4 million. </li>
<li>Establishment Labs Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESTA#NASDAQ">ESTA</a>) shares rose 14.43% to $44.01. The market value of their outstanding shares is at $1.1 billion. The company's, Q4 earnings came out today. </li>
<li>Voyager Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VYGR#NASDAQ">VYGR</a>) shares moved upwards by 11.44% to $10.0. The market value of their outstanding shares is at $555.6 million. As per the press release, Q4 earnings came out today. </li>
<li>Natera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRA#NASDAQ">NTRA</a>) shares moved upwards by 9.73% to $84.0. The company's market cap stands at $10.0 billion. As per the press release, Q4 earnings came out today. </li>
<li>MiMedx Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXG#NASDAQ">MDXG</a>) shares increased by 9.14% to $8.95. The company's market cap stands at $1.3 billion. As per the press release, Q4 earnings came out today. </li>
<li>Lexaria Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEXX#NASDAQ">LEXX</a>) shares increased by 9.01% to $2.78. The market value of their outstanding shares is at $33.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Butterfly Network (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFLY#NYSE">BFLY</a>) shares decreased by 16.9% to $1.23 during Wednesday's after-market session. The company's market cap stands at $254.7 million. As per the press release, Q4 earnings came out today. </li>
<li>Ampio Pharmaceuticals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AMPE#AMEX">AMPE</a>) shares decreased by 10.87% to $2.05. The company's market cap stands at $2.3 million. </li>
<li>ClearPoint Neuro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPT#NASDAQ">CLPT</a>) stock fell 10.63% to $6.9. The market value of their outstanding shares is at $169.8 million. </li>
<li>Schrodinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDGR#NASDAQ">SDGR</a>) stock declined by 9.98% to $28.24. The market value of their outstanding shares is at $2.0 billion. The company's, Q4 earnings came out today. </li>
<li>GlucoTrack (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) shares fell 9.44% to $0.24. The market value of their outstanding shares is at $5.8 million. </li>
<li>SILO Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILO#NASDAQ">SILO</a>) shares fell 7.41% to $1.5. The market value of their outstanding shares is at $4.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GCTK

LEXX

MDXG

NTRA

SILO

VYGR

12 Health Care Stocks Moving In Wednesday's After-Market Session

- SEC Filing
&nbsp;
On February 26, 2024, Ampio Pharmaceuticals, Inc. (the "Company") provided a notice to H.C. Wainwright &amp; Co., LLC to terminate that certain At The Marketing Offering Agreement, dated September 18, 2023, by and between the Company and H.C. Wainwright &amp; Co., LLC (the "ATM Agreement"), establishing an at-the-market equity distribution program for the offer and sale from time to time shares of the Company's common stock, par value $0.0001. In accordance with the ATM Agreement, the termination will be effective March 6, 2024.
&nbsp;
In connection with the termination of the ATM Agreement, the Company filed on February 28, 2024 a post-effective amendment to its Registration Statement on Form S-3 (File No. 333-274558) to withdraw and remove from registration any and all Company securities that remain unsold or otherwise unissued under such Registration Statement, including shares of the Company's common stock that were covered by the at-the-market offering agreement prospectus filed as part of the Registration Statement.

Offerings

Ampio Pharmaceuticals Files FormRW To Terminate That Certain At The Marketing Offering Agreement, Dated September 18, 2023

The Company&#39;s management and the Board are currently assessing both internal and external options.&nbsp;

Ampiolans To Take Immediate Actions To Preserve Its Cash In Order To Be Able To Adequately Fund Any Option Identified By Board

Ampio Says Efficacy Results From Recently Completed Nonclinical Pre-IND Enabling Studies With OA-201 Do Not Support An IND Submission Which Was Anticipated In Early 2025

Legal

Ampio Reaches Settlement In Principle In Pending Securities Fraud Class Action

Shares of RxSight, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rxst#NASDAQ">RXST</a>) rose sharply during Monday&rsquo;s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates.
Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.
RxSight shares jumped 20% to $44.31 on Monday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Harpoon Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/harp#NASDAQ">HARP</a>) shares jumped 111.2% to $22.28 after Merck announced it will acquire the company for $23 per share in cash.</li>
<li>Ambrx Biopharma Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amam#NASDAQ">AMAM</a>) jumped 98.1% to $27.00 after Johnson &amp; Johnson announced it will acquire the company in an all-cash merger for a total equity value of approximately $2 billion.</li>
<li>Spectaire Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spec#NASDAQ">SPEC</a>) jumped 75.2% to $2.96.</li>
<li>Nkarta, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nktx#NASDAQ">NKTX</a>) rose 51% to $9.17 as the company announced updated corporate presentation to reflect business and strategic update.</li>
<li>Universe Pharmaceuticals INC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/upc#NASDAQ">UPC</a>) gained 42% to $2.22.</li>
<li>Elevation Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elev#NASDAQ">ELEV</a>) jumped 39.2% to $1.2193.</li>
<li>NexImmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nexi#NASDAQ">NEXI</a>) rose 34.7% to $8.32.</li>
<li>Praxis Precision Medicines, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prax#NASDAQ">PRAX</a>) rose 34% to $33.76 as the company issued update on advancing clinical stage portfolio.</li>
<li>QuantaSing Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qsg#NASDAQ">QSG</a>) gained 31% to $2.0563.</li>
<li>Butterfly Network, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bfly#NASDAQ">BFLY</a>) rose 29.7% to $1.31 as the company announced FDA clearance of handheld ultrasound system, Butterfly iQ3.</li>
<li>Venus Concept Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vero#NASDAQ">VERO</a>) climbed 28% to $1.51.</li>
<li>Ardelyx, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ardx#NASDAQ">ARDX</a>) gained 25.5% to $7.73 after the company provided an update on its progress in 2023 and initial expectations for 2024.</li>
<li>BioCryst Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcrx#NASDAQ">BCRX</a>) rose 20.8% to $7.36 after the company issued preliminary Q4 revenue guidance above estimates. Also the company said it is approaching positive EPS and cash flow in 2H 2025.</li>
<li>Axonics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axnx#NASDAQ">AXNX</a>) jumped 19.9% to $69.03 after the company announced a deal to be acquired by Boston Scientific.</li>
<li>Crocs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crox#NASDAQ">CROX</a>) jumped 18.8% to $102.69 after the company issued strong Q4 and full year 2023 guidance.</li>
<li>LendingTree, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tree#NASDAQ">TREE</a>) rose 17.3% to $33.50.</li>
<li>Wolverine World Wide, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/www#NYSE">WWW</a>) jumped 16.7% to $9.02. Wolverine Worldwide affirmed preliminary 2023 financial results in line with guidance.</li>
<li>Ampio Pharmaceuticals, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ampe#NYSE">AMPE</a>) gained 16.4% to $2.0799 after falling around 8% on Friday.</li>
<li>Shattuck Labs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sttk#NASDAQ">STTK</a>) gained 15.2% to $9.52.</li>
<li>Vincerx Pharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vinc#NASDAQ">VINC</a>) shares rose 14.3% to $1.36 after the company announced compelling clinical efficacy of enitociclib in combination with venetoclax and prednisone in lymphoma.</li>
<li>Cyclacel Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cycc#NASDAQ">CYCC</a>) shares gained 14.1% to $2.84 after jumping over 10% on Friday.</li>
<li>Silk Road Medical, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/silk#NASDAQ">SILK</a>) rose 13.4% to $12.91.</li>
<li>OPKO Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opk#NASDAQ">OPK</a>) jumped 12.5% to $1.00.</li>
<li>Avadel Pharmaceuticals plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avdl#NASDAQ">AVDL</a>) gained 12% to $16.68 after the company issued a business update.</li>
<li>Fastly, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fsly#NYSE">FSLY</a>) jumped 10.5% to $17.88 after RBC Capital upgraded the stock from Underperform to Sector Perform and raised its price target from $12 to $18.</li>
<li>Upwork Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/upwk#NASDAQ">UPWK</a>) gained 10.3% to $15.51 after Jefferies upgraded the stock from Hold to Buy and raised its price target from $13 to $20.</li>
<li>Commercial Metals Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cmc#NYSE">CMC</a>) rose 6.2% to $51.21 following strong quarterly results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>LumiraDx Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lmdx#NASDAQ">LMDX</a>) shares fell 45.5% to $0.0187. LumiraDx announced its securities will be suspended from trading on Nasdaq at the open of business on Jan. 9th.</li>
<li>Top KingWin Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcjh#NASDAQ">TCJH</a>) dipped 38.8% to $1.18.</li>
<li>Solo Brands, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dtc#NYSE">DTC</a>) dipped 38.7% to $3.6150 after the company lowered full year 2023 revenue guidance below estimates.</li>
<li>Dada Nexus Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dada#NASDAQ">DADA</a>) shares dipped 38.1% to $1.95. Dada Nexus said in the course of its routine internal audit, certain suspicious practices were identified that may cast doubt on certain revenues from the company&#39;s online advertising and marketing services in 2023.</li>
<li>Prothena Corporation plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prta#NASDAQ">PRTA</a>) fell 25.1% to $30.45 after the company issued updates on PRX012, PRX123, Birtamimab and Portfolio programs.</li>
<li>Jin Medical International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zjyl#NASDAQ">ZJYL</a>) fell 23.4% to $95.00.</li>
<li>MMTec, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtc#NASDAQ">MTC</a>) fell 22.4% to $1.82.</li>
<li>Evolve Transition Infrastructure LP (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snmp#NASDAQ">SNMP</a>) tumbled 20.8% to $1.33.</li>
<li>Revance Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvnc#NASDAQ">RVNC</a>) fell 20.1% to $6.68 after the company issued preliminary Q4 and FY23 financial results and guidance.</li>
<li>Banzai International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bnzi#NASDAQ">BNZI</a>) shares fell 19.3% to $2.07. Banzai shares jumped around 55% on Friday after the company signed an LOI to acquire IGLeads.</li>
<li>Northern Dynasty Minerals Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nak#NYSE">NAK</a>) dipped 18.8% to $0.3107.</li>
<li>The Arena Group Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aren#NYSE">AREN</a>) shares fell 18.2% to $1.7603 after dipping 17% on Friday.</li>
<li>The Arena Group Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aren#NASDAQ">AREN</a>) dipped 18% to $ 1.7650.</li>
<li>Inspire Veterinary Partners, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ivp#NASDAQ">IVP</a>) declined 16.8% to $0.1881. Inspire Veterinary Partners recently filed a prospectus related to up to a $5 million public offering</li>
<li>Pacific Biosciences of California, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pacb#NASDAQ">PACB</a>) fell 15.1% to $7.99. Pacific Biosciences of California said it sees preliminary FY23 revenue of $200.5 million.</li>
<li>REGENXBIO Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rgnx#NASDAQ">RGNX</a>) fell 14.8% to $14.01. US District Court issued decision on REGENXBIO and University of Pennsylvania NAV technology patent infringement lawsuit.</li>
<li>Revance Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvnc#NASDAQ">RVNC</a>) fell 13.6% to $7.21. Revance issued corporate update, preliminary Q4 and FY23 financial results, and financial outlook.</li>
<li>BioSig Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bsgm#NASDAQ">BSGM</a>) fell 13.6% to $0.35. On Jan. 5, BioSig Technologies received a letter from Nasdaq notifying company has regained compliance with Nasdaq Listing Rule 5550(b)(2).</li>
<li>Bright Health Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bhg#NYSE">BHG</a>) dipped 12.8% to $10.00.</li>
<li>Safe and Green Development Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgd#NASDAQ">SGD</a>) shares fell 11.3% to $1.80 after jumping 49% on Friday.</li>
<li>Argo Blockchain plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arbk#NASDAQ">ARBK</a>) fell 11.1% to $3.11 after announcing &pound;7.8 million ($9.9 million) placing.</li>
<li>Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/shph#NASDAQ">SHPH</a>) dipped 10.7% to $0.5146. Shuttle Pharmaceuticals received FDA approval to proceed with Phase II clinical trial of ropidoxuridine for the treatment of patients with glioblastoma.</li>
<li>Paragon 28, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fna#NYSE">FNA</a>) fell 9.6% to $11.83. Paragon 28 said it sees preliminary fourth-quarter revenue of $60.3 million to $60.6 million.</li>
<li>Sharps Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stss#NASDAQ">STSS</a>) fell 8.3% to $0.4032 after jumping 12% on Friday.</li>
<li>Dynavax Technologies Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dvax#NASDAQ">DVAX</a>) dipped 7.5% to $13.63. Dynavax sees preliminary 2023 HEPLISAV-B vaccine net product revenue of $213 million.</li>
<li>The Boeing Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ba#NYSE">BA</a>) fell 7% to $231.69 after an exit door blew out of a 737 aircraft during a commercial flight.</li>
<li>Spirit AeroSystems Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spr#NYSE">SPR</a>) fell 6.5% to $29.67 after an exit door blew out of a 737 aircraft during a commercial flight. Spirit Aerosystems was a vendor involved with the faulty door.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/01/36528274/cramer-says-this-major-healthcare-stock-is-ridiculously-cheap-and-doing-so-many-great-th"> Cramer Says This Major Healthcare Stock Is &#39;Ridiculously Cheap And Doing So Many Great Things&#39; </a>

Penny Stocks

Small Cap

Intraday Update

Markets

Trading Ideas

AMAM

ARBK

ARDX

AREN

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

AXNX

BCRX

BNZI

BSGM

CROX

CYCC

DADA

DVAX

ELEV

FSLY

HARP

LMDX

NEXI

NKTX

PACB

PRAX

PRTA

RGNX

RXST

SHPH

SILK

SNMP

SPEC

STSS

STTK

TCJH

TREE

UPWK

VERO

VINC

ZJYL

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of LumiraDx Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lmdx#NASDAQ">LMDX</a>) shares fell sharply in pre-market trading.
LumiraDx announced its securities will be suspended from trading on Nasdaq at the open of business on Jan. 9th.
LumiraDx shares dipped 30.5% to $0.0239 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3>Gainers</h3>
<ul>
<li>Harpoon Therapeutics, Inc.(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/harp#NASDAQ">HARP</a>) gained 98.6% to $20.95 in pre-market trading. Bloomberg reported that Merck is in advanced talks to buy Harpoon Therapeutics for $23 per share.</li>
<li>Vincerx Pharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vinc#NASDAQ">VINC</a>) shares rose 56.3% to $1.86 in pre-market trading after the company announced compelling clinical efficacy of enitociclib in combination with venetoclax and prednisone in lymphoma.</li>
<li>Spectaire Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spec#NASDAQ">SPEC</a>) shares gained 46.6% to $2.48 in pre-market trading after gaining 7% on Friday.</li>
<li>Cyclacel Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cycc#NASDAQ">CYCC</a>) shares gained 36.5% to $3.40 in pre-market trading after jumping over 10% on Friday.</li>
<li>Vision Marine Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vmar#NASDAQ">VMAR</a>) shares climbed 30.4% to $1.24 in pre-market trading.</li>
<li>Heron Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hrtx#NASDAQ">HRTX</a>) shares rose 14.1% to $2.02 in pre-market trading. Heron Therapeutics announced a five-year distribution partnership with CrossLink Life Sciences to expand promotional effort for ZYNRELEF.</li>
<li>Ampio Pharmaceuticals, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ampe#NYSE">AMPE</a>) gained 12.4% to $2.00 in pre-market trading after falling around 8% on Friday.</li>
<li>NanoString Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nstg#NASDAQ">NSTG</a>) shares rose 11.8% to $0.6060 in pre-market trading. NanoString&#39;s CosMx SMI achieved whole transcriptome imaging at single-cell resolution.</li>
<li>eFFECTOR Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eftr#NASDAQ">EFTR</a>) gained 9.2% to $0.5799 in pre-market trading.</li>
<li>Heart Test Laboratories, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hscs#NASDAQ">HSCS</a>) gained 8.8% to $0.1799 in pre-market trading. Heart Test Laboratories received decision to grant European Patent &quot;Electrocardiogram-Based Assessment of Diastolic Function (Using Machine-Learned Computational Models).</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Banzai International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bnzi#NASDAQ">BNZI</a>) shares fell 18.3% to $2.10 in pre-market trading. Banzai shares jumped around 55% on Friday after the company signed an LOI to acquire IGLeads.</li>
<li>The Arena Group Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aren#NYSE">AREN</a>) shares fell 17.2% to $1.78 in pre-market trading after dipping 17% on Friday.</li>
<li>Spirit AeroSystems Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spr#NYSE">SPR</a>) shares fell 16.4% to $26.53 in pre-market trading. The FAA ordered the temporary grounding of certain Boeing 737 Max 9 aircraft operated by U.S. Airlines or in U.S. territory.</li>
<li>Charge Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crge#NASDAQ">CRGE</a>) shares fell 14.8% to $0.0793 in pre-market trading after dipping around 11% on Friday.</li>
<li>Safe and Green Development Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgd#NASDAQ">SGD</a>) shares fell 14.3% to $1.74 in pre-market trading after jumping 49% on Friday.</li>
<li>Future FinTech Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ftft#NASDAQ">FTFT</a>) shares fell 13.4% to $1.23 in pre-market trading after dipping 22% on Friday.</li>
<li>Sharps Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stss#NASDAQ">STSS</a>) fell 11.1% to $0.40 in pre-market trading after jumping 12% on Friday.</li>
<li>Ainos, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aimd#NASDAQ">AIMD</a>) shares fell 11% to $2.44 in pre-market trading after jumping over 58% on Friday.</li>
<li>Brera Holdings PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brea#NASDAQ">BREA</a>) fell 10.1% to $0.6566 in pre-market trading.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/01/36528215/commercial-metals-boot-barn-and-3-stocks-to-watch-heading-into-monday"> Commercial Metals, Boot Barn And 3 Stocks To Watch Heading Into Monday </a>

Pre-Market Outlook

AIMD

BREA

CRGE

EFTR

FTFT

HRTX

HSCS

NSTG

VMAR

Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>Harpoon Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HARP#NASDAQ">HARP</a>) stock increased by 110.9% to $22.25 during Monday's pre-market session. The company's market cap stands at $376.7 million. </li>
<li>Ambrx Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAM#NASDAQ">AMAM</a>) stock rose 101.76% to $27.5. The market value of their outstanding shares is at $1.7 billion. </li>
<li>Vincerx Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINC#NASDAQ">VINC</a>) shares moved upwards by 52.54% to $1.8. The company's market cap stands at $38.4 million. </li>
<li>Ampio Pharmaceuticals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AMPE#AMEX">AMPE</a>) stock rose 27.52% to $2.27. The company's market cap stands at $1.8 million. </li>
<li>Cyclacel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) stock increased by 25.7% to $3.13. The market value of their outstanding shares is at $3.1 million. </li>
<li>Axonics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXNX#NASDAQ">AXNX</a>) shares rose 20.91% to $69.61. The company's market cap stands at $3.5 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>LumiraDx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMDX#NASDAQ">LMDX</a>) shares decreased by 32.6% to $0.02 during Monday's pre-market session. The company's market cap stands at $7.4 million. </li>
<li>Sharps Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STSS#NASDAQ">STSS</a>) shares fell 15.43% to $0.38. The company's market cap stands at $5.8 million. </li>
<li>Ainos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIMD#NASDAQ">AIMD</a>) stock fell 12.41% to $2.4. The company's market cap stands at $11.2 million. </li>
<li>Biofrontera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFRI#NASDAQ">BFRI</a>) stock fell 8.52% to $2.58. The company's market cap stands at $3.9 million. </li>
<li>Elevation Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELEV#NASDAQ">ELEV</a>) shares decreased by 8.32% to $0.8. The market value of their outstanding shares is at $34.0 million. </li>
<li>Cytokinetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>) stock decreased by 8.25% to $86.0. The company's market cap stands at $8.4 billion. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BFRI

CYTK

12 Health Care Stocks Moving In Monday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Heart Test Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSCS#NASDAQ">HSCS</a>) stock moved upwards by 41.6% to $0.23 during Friday's after-market session. The market value of their outstanding shares is at $14.8 million. </li>
<li>MyMD Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYMD#NASDAQ">MYMD</a>) shares increased by 9.52% to $0.23. The market value of their outstanding shares is at $11.7 million. </li>
<li>Asensus Surgical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ASXC#AMEX">ASXC</a>) stock increased by 9.37% to $0.35. The company's market cap stands at $92.5 million. </li>
<li>Journey Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DERM#NASDAQ">DERM</a>) shares moved upwards by 6.58% to $5.34. The company's market cap stands at $98.8 million. </li>
<li>Lucy Scientific Discovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSDI#NASDAQ">LSDI</a>) stock rose 5.71% to $0.21. The company's market cap stands at $3.7 million. </li>
<li>Ampio Pharmaceuticals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AMPE#AMEX">AMPE</a>) stock increased by 5.61% to $1.88. The company's market cap stands at $1.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Sharps Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STSS#NASDAQ">STSS</a>) stock fell 13.4% to $0.39 during Friday's after-market session. The company's market cap stands at $5.9 million. </li>
<li>Ainos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIMD#NASDAQ">AIMD</a>) stock declined by 8.03% to $2.52. The market value of their outstanding shares is at $11.7 million. </li>
<li>Dermata Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRMA#NASDAQ">DRMA</a>) stock fell 6.48% to $0.64. The market value of their outstanding shares is at $2.2 million. </li>
<li>Assertio Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASRT#NASDAQ">ASRT</a>) stock declined by 5.69% to $0.96. The market value of their outstanding shares is at $91.0 million. </li>
<li>CareMax (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMAX#NASDAQ">CMAX</a>) stock declined by 5.38% to $0.38. The company's market cap stands at $42.6 million. </li>
<li>Synaptogenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPX#NASDAQ">SNPX</a>) shares declined by 5.19% to $0.25. The market value of their outstanding shares is at $4.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASRT

ASXC

CMAX

DERM

DRMA

LSDI

MyMD Pharmaceuticals, Inc. - Common Stock

MYMD

SNPX

12 Health Care Stocks Moving In Friday's After-Market Session

Shares of DouYu International Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/doyu#NASDAQ">DOYU</a>) rose sharply during Thursday&rsquo;s session after announcing a share repurchase program.
DouYu plans repurchase of up to $20 million of ordinary shares in the form of ADSS during period of up to twelve months commencing on Jan. 1, 2024.
DouYu International shares jumped 14.2% to $0.8320 on Thursday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Nova LifeStyle, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvfy#NASDAQ">NVFY</a>) shares jumped 204% to $4.71.</li>
<li>Cingulate Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cing#NASDAQ">CING</a>) climbed 157.4% to $10.27. On Tuesday, Cingulate received FDA guidance for CTx-1301 (dexmethylphenidate), its lead investigational product candidate for attention deficit hyperactivity disorder (ADHD).</li>
<li>Bone Biologics Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bblg#NASDAQ">BBLG</a>) gained 62.2% to $7.54.</li>
<li>SenesTech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snes#NASDAQ">SNES</a>) shares climbed 50.7% to $1.30. HC Wainwright &amp; Co. analyst Amit Dayal maintained SenesTech with a Buy, adjusting target to $3.5 from $4.</li>
<li>Microbot Medical Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mbot#NASDAQ">MBOT</a>) rose 38% to $1.8301 after the company announced the completion of its GLP pivotal pre-clinical study.</li>
<li>Sidus Space, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sidu#NASDAQ">SIDU</a>) gained 32% to $5.81.</li>
<li>DatChat, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dats#NASDAQ">DATS</a>) rose 30% to $2.62. DatChat announced the release of its new AI social gaming platform and developer program for game designers and content creators.</li>
<li>SEALSQ Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/laes#NASDAQ">LAES</a>) gained 25% to $1.4424. SEALSQ disclosed that its post-quantum semiconductor technology, based on cutting-edge cryptographic algorithms, is specifically designed to withstand attacks from and secure <a href="https://www.benzinga.com/money/best-cryptocurrency/">cryptocurrency</a> transactions against the looming threat of quantum computing.</li>
<li>Ocean Biomedical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocea#NASDAQ">OCEA</a>) surged 21.4% to $0.7299.</li>
<li>DSS, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dss#NYSE">DSS</a>) jumped 21% to $0.1477.</li>
<li>RenovoRx, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnxt#NASDAQ">RNXT</a>) gained 20% to $1.2599.</li>
<li>Arcutis Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arqt#NASDAQ">ARQT</a>) rose 20% to $3.6250. The FDA recently approved the company&#39;s Zoryve topical foam, 0.3% for seborrheic dermatitis in individuals nine years and older.</li>
<li>Envoy Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coch#NASDAQ">COCH</a>) gained 17.1% to $1.98.</li>
<li>Flux Power Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flux#NASDAQ">FLUX</a>) rose 16.6% to $4.00.</li>
<li>Next.e.GO N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egox#NASDAQ">EGOX</a>) shares rose 14.5% to $0.5321 after gaining 6% on Wednesday.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iova#NASDAQ">IOVA</a>) gained 14.2% to $8.26. Iovance Biotherapeutics announced a clinical program update for LN-145 TIL therapy in non-small lung cancer (NSCLC).</li>
<li>Ampio Pharmaceuticals, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ampe#NYSE">AMPE</a>) shares gained 11.8% to $2.4611 after jumping 20% on Wednesday.</li>
<li>Altice USA, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atus#NASDAQ">ATUS</a>) rose 11.8% to $3.41 after gaining around 12% on Wednesday.</li>
<li>Esperion Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/espr#NASDAQ">ESPR</a>) jumped 11.4% to $3.1550.</li>
<li>Altice USA, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/atus#NYSE">ATUS</a>) gained 10.1% to $3.36.</li>
<li>Lufax Holding Ltd (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lu#NYSE">LU</a>) jumped 9.3% to $3.05.</li>
<li>UP Fintech Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tigr#NASDAQ">TIGR</a>) gained 9.2% to $4.4980.</li>
<li>TeraWulf Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wulf#NASDAQ">WULF</a>) shares gained 8.2% to $3.1150 after gaining around 30% on Wednesday.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Cytosorbents Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ctso#NASDAQ">CTSO</a>) shares fell 40.2% to $0.9733. CytoSorbents released an update on the initial data analysis of primary safety and effectiveness endpoints and the final independent Data and Safety Monitoring Board for the pivotal U.S. and Canadian STAR-T trial.</li>
<li>Bluejay Diagnostics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bjdx#NASDAQ">BJDX</a>) fell 29.5% to $1.2691. Bluejay Diagnostics announced pricing of $3.5 million public offering of 2,692,308 shares at $1.30 per share.</li>
<li>Velo3D, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vld#NYSE">VLD</a>) fell 25.7% to $0.4683 after the company announced a registered direct offering.</li>
<li>Meihua International Medical Technologies Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mhua#NASDAQ">MHUA</a>) declined 23% to $2.0808. Meihua International Medical Technologies entered into securities purchase agreement with investors to issue and sell initial $6 million tranche in offering of $50.5 million of its securities.</li>
<li>IMAC Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/back#NASDAQ">BACK</a>) dipped 21.4% to $2.1206.</li>
<li>Sentage Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sntg#NASDAQ">SNTG</a>) fell 21% to $1.58. Sentage Holdings recently reported a loss of 46 cents per share in the six months ended June 30, 2023, versus a year-ago loss of 41 cents per share.</li>
<li>Airship AI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aisp#NASDAQ">AISP</a>) declined 17% to $2.14.</li>
<li>NeoGenomics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/neo#NASDAQ">NEO</a>) fell 16.4% to $17.13 after Natera won a preliminary injuction in a patent infringement lawsuit against NeoGenomics&#39; RaDar test.</li>
<li>Baosheng Media Group Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/baos#NASDAQ">BAOS</a>) fell 16.3% to $3.58.</li>
<li>Linkage Global Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgcb#NASDAQ">LGCB</a>) declined 16.2% to $1.3357.</li>
<li>Bit Brother Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bets#NASDAQ">BETS</a>) fell 14.9% to $0.0114.</li>
<li>RiskOn International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roi#NASDAQ">ROI</a>) fell 14.8% to $0.3661. Ault Alliance disclosed that its majority beneficially owned subsidiary, RiskOn International, expects to announce its new generative artificial intelligence platform and launch a relationship with its principal technology partner on Jan. 3, 2024.</li>
<li>First Wave BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fwbi#NASDAQ">FWBI</a>) fell 14.6% to $4.7199. First Wave BioPharma recently announced that it entered a non-binding term sheet to sell its Niclosamide program for the treatment of inflammatory bowel diseases.</li>
<li>Hallmark Financial Services, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hall#NASDAQ">HALL</a>) fell 13.7% to $1.0101 after dipping 25% on Wednesday. On Dec. 26, the company announced that it intends to voluntary delist from the Nasdaq.</li>
<li>AEye, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lidr#NASDAQ">LIDR</a>) shares fell 12.4% to $2.32 after gaining 19% on Wednesday.</li>
<li>Calliditas Therapeutics AB (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/calt#NASDAQ">CALT</a>) declined 11.6% to $25.19. Calliditas Therapeutics recently announced FDA approval of TARPEYO.</li>
<li>Wheels Up Experience Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/up#NYSE">UP</a>) fell 10.8% to $5.12.</li>
<li>Hut 8 Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hut#NASDAQ">HUT</a>) fell 10.1% to $16.29.</li>
<li>Iris Energy Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iren#NASDAQ">IREN</a>) dipped 9.7% to $8.64. Iris Energy recently announced that its 10 EH/s expansion program is fully funded following the completion of the targeted equity raising program.</li>
<li>MyMD Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mymd#NASDAQ">MYMD</a>) shares fell 9.4% to $0.3031 after jumping over 40% on Wednesday.</li>
<li>Cyclo Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyth#NASDAQ">CYTH</a>) shares fell 8.6% to $1.4973. Cyclo Therapeutics announced the closing of merger with Applied Molecular Transport Inc.</li>
<li>1847 Holdings LLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/efsh#NASDAQ">EFSH</a>) fell 8.2% to $0.4773. 1847 Holdings said it will effect a 1-for-4 reverse split of its common shares that will become effective on Jan. 8, 2024.</li>
<li>Bridgeline Digital, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blin#NASDAQ">BLIN</a>) fell 5.3% to $0.8501 following the release of fourth-quarter results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/23/12/36395783/amazon-adobe-and-2-other-stocks-insiders-are-selling"> Amazon, Adobe And 2 Other Stocks Insiders Are Selling</a>

AISP

ARQT

ATUS

BACK

BAOS

BBLG

BETS

BJDX

BLIN

CALT

CING

CTSO

CYTH

DATS

DOYU

EFSH

EGOX

ESPR

FLUX

FWBI

HALL

IOVA

IREN

LAES

LGCB

LIDR

MBOT

MHUA

NVFY

OCEA

RNXT

SIDU

SNES

SNTG

TIGR

WULF

Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Bridgeline Digital, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blin#NASDAQ">BLIN</a>) fell sharply in pre-market following the release of fourth-quarter results.
Bridgeline Digital posted a narrower-than-expected loss for its fourth quarter, while sales missed estimates.
Bridgeline Digital shares dipped 13.1% to $0.7805 in pre-market.
Here are some other stocks moving in pre-market trading.
<h3>Gainers</h3>
<ul>
<li>Cingulate Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cing#NASDAQ">CING</a>) shares gained 233.3% to $13.30 in pre-market trading after surging more than 90% on Wednesday.</li>
<li>SenesTech, Inc.(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snes#NASDAQ">SNES</a>) gained 91.3% to $1.65 in pre-market trading after gaining around 8% on Wednesday. SenesTech recently announced entry into a Distribution Agreement with Fruit Tree Limited and an initial order for Evolve Soft Bait in Hong Kong and Macau.</li>
<li>Nxu, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxu#NASDAQ">NXU</a>) rose 44.8% to $3.85 in pre-market trading after falling around 15% on Wednesday. Nxu executed definitive documents to finalize its strategic investment in Lynx Motors.</li>
<li>noco-noco Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ncnc#NASDAQ">NCNC</a>) shares rose 29.3% to $0.2550 in pre-market trading. Noco-Noco recently filed prospectus relates to offer and resale from time to time by selling stockholders of up to 100.3 million ordinary shares.</li>
<li>Virax Biolabs Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrax#NASDAQ">VRAX</a>) shares gained 20.7% to $1.92 in pre-market trading after gaining around 20% on Wednesday.</li>
<li>Next.e.GO N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egox#NASDAQ">EGOX</a>) shares rose 17.5% to $0.5450 in pre-market trading after gaining 6% on Wednesday.</li>
<li>Ampio Pharmaceuticals, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ampe#NYSE">AMPE</a>) shares gained 15.5% to $2.54 in pre-market trading after jumping 20% on Wednesday.</li>
<li>NFT Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mi#NYSE">MI</a>) gained 13.6% to $0.25 in pre-market trading after gaining 9% on Wednesday.</li>
<li>Advent Technologies Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adn#NASDAQ">ADN</a>) shares climbed 12.2% to $0.2610 in pre-market trading after gaining 14% on Wednesday. Advent Technologies recently announced a $2 million registered direct offering of common stock.</li>
<li>22nd Century Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xxii#NASDAQ">XXII</a>) gained 7.8% to $0.1999 in pre-market trading.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Rent the Runway, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rent#NASDAQ">RENT</a>) shares fell 37.4% to $0.3801 in pre-market trading after declining around 8% on Wednesday. Rent The Runway recently reported worse-than-expected third-quarter revenue results and issued FY23 revenue guidance below estimates.</li>
<li>Cyclo Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyth#NASDAQ">CYTH</a>) shares fell 20.6% to $1.30 in pre-market trading. Cyclo Therapeutics announced the closing of merger with Applied Molecular Transport Inc.</li>
<li>RiskOn International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roi#NASDAQ">ROI</a>) shares fell 15.8% to $0.3620 in pre-market trading. RiskOn International shares jumped 205% on Wednesday after the company said it expects to announce its new generative AI platform and unveil a principal technology partner on Jan. 3.</li>
<li>Asset Entities Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asst#NASDAQ">ASST</a>) shares fell 14.1% to $0.5102 in pre-market trading after declining 16% on Wednesday.</li>
<li>Earlyworks Co., Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elws#NASDAQ">ELWS</a>) shares fell 12.8% to $0.71 in pre-market trading after gaining around 69% on Wednesday.</li>
<li>MyMD Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mymd#NASDAQ">MYMD</a>) shares fell 12.2% to $0.2940 in pre-market trading after jumping over 40% on Wednesday.</li>
<li>1847 Holdings LLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/efsh#NASDAQ">EFSH</a>) fell 12.2% to $0.4558 in pre-market trading.</li>
<li>1847 Holdings said it will effect a 1-for-4 reverse split of its common shares that will become effective on Jan. 8, 2024.</li>
<li>Hallmark Financial Services, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hall#NASDAQ">HALL</a>) fell 11.1% to $1.04 in pre-market trading after dipping 25% on Wednesday. On Dec. 26, the company announced that it intends to voluntary delist from the Nasdaq.</li>
<li>AEye, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lidr#NASDAQ">LIDR</a>) shares fell 8.7% to $2.42 in pre-market trading after gaining 19% on Wednesday.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/12/36406979/investor-sentiment-edges-lower-dow-jumps-over-100-points"> Investor Sentiment Edges Lower; Dow Jumps Over 100 Points</a>

ASST

ELWS

NCNC

RENT

VRAX

XXII

Why Bridgeline Digital Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>Cyclo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTH#NASDAQ">CYTH</a>) stock rose 34.1% to $2.2 during Wednesday's after-market session. The market value of their outstanding shares is at $50.0 million. </li>
<li>Cingulate (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CING#NASDAQ">CING</a>) shares moved upwards by 22.05% to $4.87. The market value of their outstanding shares is at $4.5 million. </li>
<li>Virax Biolabs Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAX#NASDAQ">VRAX</a>) shares rose 10.69% to $1.76. The company's market cap stands at $3.1 million. </li>
<li>Inspire Veterinary (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVP#NASDAQ">IVP</a>) shares rose 8.64% to $0.37. The market value of their outstanding shares is at $3.3 million. </li>
<li>CytoMed Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDTC#NASDAQ">GDTC</a>) stock moved upwards by 7.69% to $5.6. The market value of their outstanding shares is at $64.5 million. </li>
<li>Nemaura Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMRD#NASDAQ">NMRD</a>) shares moved upwards by 7.49% to $0.21. The company's market cap stands at $6.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Edgewise Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWTX#NASDAQ">EWTX</a>) stock decreased by 14.5% to $10.35 during Wednesday's after-market session. The company's market cap stands at $656.8 million. </li>
<li>NKGen Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKGN#NASDAQ">NKGN</a>) shares fell 9.64% to $3.0. The market value of their outstanding shares is at $65.6 million. </li>
<li>Panbela Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBLA#NASDAQ">PBLA</a>) stock decreased by 6.13% to $0.92. The market value of their outstanding shares is at $6.2 million. </li>
<li>Ampio Pharmaceuticals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AMPE#AMEX">AMPE</a>) shares fell 5.91% to $2.07. The company's market cap stands at $1.7 million. </li>
<li>Autolus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUTL#NASDAQ">AUTL</a>) shares fell 5.9% to $6.24. The company's market cap stands at $1.0 billion. </li>
<li>Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) stock declined by 5.77% to $0.57. The market value of their outstanding shares is at $1.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AUTL

EWTX

GDTC

NKGN

NMRD

NUWE

PBLA

<h3>Gainers</h3>
<ul>
<li>Lucy Scientific Discovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSDI#NASDAQ">LSDI</a>) shares increased by 46.4% to $0.3 during Friday's after-market session. The market value of their outstanding shares is at $5.2 million. </li>
<li>Lexeo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXEO#NASDAQ">LXEO</a>) stock rose 23.53% to $19.0. The market value of their outstanding shares is at $478.2 million. </li>
<li>NexImmune (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXI#NASDAQ">NEXI</a>) shares moved upwards by 20.0% to $7.26. The market value of their outstanding shares is at $7.6 million. </li>
<li>Virios Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRI#NASDAQ">VIRI</a>) stock moved upwards by 9.32% to $0.62. The company's market cap stands at $11.9 million. </li>
<li>TransCode Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) stock rose 8.08% to $0.24. The market value of their outstanding shares is at $4.7 million. </li>
<li>Conduit Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDT#NASDAQ">CDT</a>) shares increased by 6.04% to $5.61. The market value of their outstanding shares is at $408.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Telesis Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) shares fell 15.4% to $0.37 during Friday's after-market session. The market value of their outstanding shares is at $11.1 million. </li>
<li>SeaStar Medical Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICU#NASDAQ">ICU</a>) stock decreased by 11.46% to $0.48. The market value of their outstanding shares is at $17.8 million. </li>
<li>Eterna Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERNA#NASDAQ">ERNA</a>) shares fell 8.35% to $1.12. The market value of their outstanding shares is at $6.0 million. </li>
<li>Coya Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COYA#NASDAQ">COYA</a>) stock decreased by 7.37% to $6.41. The market value of their outstanding shares is at $64.2 million. </li>
<li>Ampio Pharmaceuticals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AMPE#AMEX">AMPE</a>) stock fell 6.84% to $3.0. The company's market cap stands at $2.4 million. </li>
<li>PAVmed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAVM#NASDAQ">PAVM</a>) shares fell 6.67% to $0.28. The company's market cap stands at $33.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

COYA

ERNA

LXEO

PAVM

RNAZ

TBIO

VIRI

Ampio Pharmaceuticals, Inc. (AMEX:AMPE) shares are trading lower Friday after spiking more than 200% on Thursday. Here&#39;s a <a href="https://www.benzinga.com/news/23/12/36047667/why-genesco-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-fridays-mid-day-se">look at what&#39;s going on: </a>
What To Know:
Shares of AMPE are falling on heavy trading volume Friday. According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, more than 738 thousand shares have been traded in the session, compared to the stock&#39;s 100-day average volume of less than 332 thousand shares. Ampio Pharmaceuticals&#39; stock has a float of less than 815 thousand shares.
Ampio Pharmaceuticals Inc. is a biopharmaceutical company focused on the clinical development of Ampion which is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19-induced respiratory distress.
Related News: <a href="https://www.benzinga.com/markets/penny-stocks/23/11/36030452/meme-stocks-rally-to-the-moon-or-failure-to-launch">Meme Stocks Rally: To The Moon Or Failure To Launch?</a>
AMPE Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Ampio Pharmaceuticals shares are down by 44% at $3.20 at the time of publication.
Image: PublicDomainPictures from Pixabay
&nbsp;
&nbsp;

What's Going On With Ampio Pharmaceuticals Stock?

<h3>Gainers</h3>
<ul>
<li>NexImmune (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXI#NASDAQ">NEXI</a>) stock moved upwards by 540.4% to $11.07 during Friday's regular session. The market value of their outstanding shares is at $11.7 million. </li>
<li>Generation Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBIO#NASDAQ">GBIO</a>) shares rose 31.81% to $1.49. The company's market cap stands at $98.4 million. </li>
<li>Altimmune (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALT#NASDAQ">ALT</a>) shares rose 28.48% to $4.06. The market value of their outstanding shares is at $218.1 million. </li>
<li>Cyclerion Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCN#NASDAQ">CYCN</a>) stock increased by 22.01% to $2.66. The company's market cap stands at $6.5 million. </li>
<li>Processa Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) shares rose 21.87% to $0.78. The company's market cap stands at $19.2 million. </li>
<li>Genelux (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLX#NASDAQ">GNLX</a>) shares moved upwards by 21.0% to $14.4. The market value of their outstanding shares is at $384.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Ampio Pharmaceuticals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AMPE#AMEX">AMPE</a>) shares fell 42.7% to $3.3 during Friday's regular session. The company's market cap stands at $2.7 million. </li>
<li>Intelligent Bio Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INBS#NASDAQ">INBS</a>) shares declined by 28.46% to $0.3. The company's market cap stands at $2.6 million. </li>
<li>LumiraDx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMDX#NASDAQ">LMDX</a>) stock declined by 23.54% to $0.13. The market value of their outstanding shares is at $42.0 million. </li>
<li>Soligenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) stock declined by 20.41% to $0.78. The market value of their outstanding shares is at $8.0 million. </li>
<li>Cartesian Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAC#NASDAQ">RNAC</a>) shares declined by 20.0% to $1.08. The market value of their outstanding shares is at $174.8 million. </li>
<li>Ensysce Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) shares decreased by 19.79% to $0.91. The company's market cap stands at $2.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CYCN

ENSC

GBIO

GNLX

Intelligent Bio Solutions Inc. - Common Stock

INBS

PCSA

RNAC

SNGX

12 Health Care Stocks Moving In Friday's Intraday Session

Gainers
<ul>
<li>Harbor Custom Development, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcdi#NASDAQ">HCDI</a>) rose 74.2% to $1.50 after surging 24% on Thursday.</li>
<li>Altimmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alt#NASDAQ">ALT</a>) shares surged 45.5% to $4.60 after the company reported topline results from MOMENTUM 48-week Phase 2 obesity trial of pemvidutide.</li>
<li>ShiftPixy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pixy#NASDAQ">PIXY</a>) gained 44.3% to $12.05 after gaining over 43% on Thursday.</li>
<li>Elastic N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/estc#NASDAQ">ESTC</a>) gained 30.3% to $104.72 after the company reported better-than-expected second-quarter financial results and issued guidance.</li>
<li>UiPath Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/path#NYSE">PATH</a>) shares climbed 25.2% to $24.74 after the company reported upbeat third-quarter financial results on Thursday.</li>
<li>Cyclerion Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cycn#NASDAQ">CYCN</a>) rose 22.6% to $2.65.</li>
<li>CleanSpark, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clsk#NASDAQ">CLSK</a>) gained 20.6% to $7.53 following FY23 results.</li>
<li>Tenon Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tnon#NASDAQ">TNON</a>) climbed 20.5% to $2.3490.</li>
<li>Limoneira Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lmnr#NASDAQ">LMNR</a>) gained 16.5% to $17.70 as the company announced process to explore strategic alternatives to maximize value.</li>
<li>Globus Maritime Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glbs#NASDAQ">GLBS</a>) gained 15.6% to $2.44.</li>
<li>Samsara Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iot#NYSE">IOT</a>) jumped 14.9% to $31.65 after the company reported better-than-expected third-quarter financial results and issued strong guidance.</li>
<li>Olaplex Holdings Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/olpx#NASDAQ">OLPX</a>) rose 13.8% to $2.48.</li>
<li>GigaCloud Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gct#NASDAQ">GCT</a>) rose 12.9% to $10.98 after it reported third-quarter FY23 results.</li>
<li>ContextLogic Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wish#NASDAQ">WISH</a>) gained 12.2% to $5.66.</li>
<li>Domo Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/domo#NASDAQ">DOMO</a>) surged 12.3% to $10.66 following quarterly results.</li>
<li>Mativ Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/matv#NYSE">MATV</a>) gained 11.6% to $13.06. Mativ announced completion of sale of Engineered Papers business</li>
<li>Ulta Beauty, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ulta#NASDAQ">ULTA</a>) jumped 10.4% to $470.22 as the company reported upbeat sales results for its third quarter and increased the lower end of its profit and sales projections for the full year. The company also said CFO Scott Settersten plans to retire, effective April 1, 2024.</li>
<li>Upstart Holdings Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/upst#NASDAQ">UPST</a>) gained 8.8% to $29.13.</li>
<li>Marathon Digital Holdings Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) rose 8.2% to $12.95 amid strength in crypto-related stocks as Bitcoin trades near 18-month highs.</li>
<li>Fenbo Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/febo#NASDAQ">FEBO</a>) shares gained 7.8% to $4.79 after falling 11% on Thursday. Fenbo Holdings priced its IPO at $5 per share.</li>
<li>Peloton Interactive Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pton#NASDAQ">PTON</a>) climbed 7.6% to $6.09.</li>
<li>Zumiez Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zumz#NASDAQ">ZUMZ</a>) climbed 7.5% to $20.31 following third-quarter results.</li>
<li>Biora Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bior#NASDAQ">BIOR</a>) shares rose 7.3% to $1.33. Biora Therapeutics secured FDA clearance of IND application for drug/device combination BT-600 targeting treatment of ulcerative colitis.</li>
<li>Opendoor Technologies Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/open#NASDAQ">OPEN</a>) gained 7.3% to $3.23.</li>
<li>HashiCorp Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcp#NASDAQ">HCP</a>) climbed 6.6% to $22.85.</li>
<li>Marriott Vacations Worldwide Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vac#NYSE">VAC</a>) rose 5.3% to $76.78.</li>
</ul>

Losers
<ul>
<li>Polar Power, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pola#NASDAQ">POLA</a>) fell 49.3% to $0.4299. Polar Power priced public offering of 4 million common shares at $0.40 per share for gross proceeds of $1.6 million.</li>
<li>Ampio Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ampe#NASDAQ">AMPE</a>) fell 46.2% to $3.0909 after surging 194% on Thursday.</li>
<li>Smart for Life, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smfl#NASDAQ">SMFL</a>) shares fell 42.7% to $1.38 after gaining over 58% on Thursday.</li>
<li>Incannex Healthcare Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ixhl#NASDAQ">IXHL</a>) shares fell 38.6% to $4.89 after gaining 85% on Thursday.</li>
<li>Minim, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/minm#NASDAQ">MINM</a>) shares fell 24.2% to $3.40 after gaining over 386% on Thursday.</li>
<li>Genesco Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gco#NYSE">GCO</a>) fell 20.3% to $29.78 following quarterly results.</li>
<li>Soligenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sngx#NASDAQ">SNGX</a>) fell 17.1% to $0.8125. Soligenix shares jumped 136% on Thursday after the company announced it received FDA IND clearance for the Phase 2 clinical trial of dusquetide in the treatment of aphthous ulcers of Beh&ccedil;et&#39;s disease.</li>
<li>Bit Origin Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btog#NASDAQ">BTOG</a>) dipped 16.5% to $3.89.</li>
<li>Aditxt, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adtx#NASDAQ">ADTX</a>) fell 15.1% to $3.3710 after jumping 15% on Thursday.</li>
<li>PROOF Acquisition Corp I (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/paci#NYSE">PACI</a>) fell 15% to $17.00.</li>
<li>Wheeler Real Estate Investment Trust, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/whlr#NASDAQ">WHLR</a>) shares fell 13.2% to $0.3299 after declining around 25% on Thursday.</li>
<li>Vivos Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vvos#NASDAQ">VVOS</a>) fell 11% to $21.81.</li>
<li>vTv Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtvt#NASDAQ">VTVT</a>) fell 10.7% to $12.76.</li>
<li>Fathom Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fthm#NASDAQ">FTHM</a>) fell 9.4% to $2.50. Fathom Holdings announced proposed primary and secondary offering of common stock.</li>
<li>The Beachbody Company, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/body#NYSE">BODY</a>) declined 9.3% to $7.02.</li>
<li>Curis, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cris#NASDAQ">CRIS</a>) fell 7.5% to $13.23.</li>
<li>Dell Technologies Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dell#NYSE">DELL</a>) fell 4.2% to $72.64. Dell reported upbeat earnings results for its third quarter, while sales missed estimates.</li>
<li>Marvell Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrvl#NASDAQ">MRVL</a>) shares fell 3.8% to $53.63 after the company reported third-quarter earnings results.</li>
</ul>

Now Read This: <a href="https://www.benzinga.com/news/earnings/23/11/36016689/how-to-make-500-a-month-with-pfizer-stock"> How To Make $500 A Month With Pfizer Stock</a>

ADTX

BIOR

Why Genesco Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Comments

Ampio Pharmaceuticals

Notizie

Ultime notizie per Ampio Pharmaceuticals (OTC:AMPE) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO